Hepatitis B and C in children (Q37139282)

18 August 2017

1 reference

title

Hepatitis B and C in children (English)

1 reference

18 August 2017

1 reference

Evelyn K Hsu

1

1 reference

18 August 2017

Karen F Murray

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

15 April 2008

1 reference

Nature Reviews Gastroenterology & Hepatology

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

6

1 reference

18 August 2017

311-320

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpgasthep1124

18 August 2017

0 references

cites work

Horizontal transmission of hepatitis B virus in children with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

Vertical Transmission of Hepatitis B Antigen in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

The natural history of hepatitis C virus (HCV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

Strategies to prevent and control hepatitis B and C virus infections: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

High levels of hepatitis B virus DNA in body fluids from chronic carriers

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Transmission of hepatitis B in Hamburg, Germany, 1998-2002: a prospective, population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Intrafamilial prevalence of hepatitis B virus in Western Brazilian Amazon region: epidemiologic and biomolecular study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Acute hepatitis B in infants born to carrier mother with the antibody to hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Natural history of hepatitis B in perinatally infected carriers

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

1 reference

7 January 2021

Primary hepatocellular carcinoma and hepatitis B infection during childhood

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Management of hepatitis B in children

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Clinical trial of lamivudine in children with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Hepatitis C virus infection: clinical aspects and treatment with interferon alfa

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Psychiatric complications of long-term interferon alfa therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Oral antivirals for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Update on chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Active surveillance of hepatitis C infection in the UK and Ireland

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

An epidemiological survey of hepatitis C virus infection in Italian children in the decade 1990-1999.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

A prospective study on mother-to-infant transmission of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Vertically acquired paediatric coinfection with HIV and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

When does mother to child transmission of hepatitis C virus occur?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breast-feeding in transmission.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Hepatitis C and pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Perinatal hepatitis C virus infection: diagnosis and management

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Hepatitis C -- identifying patients with progressive liver injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Clinical and histologic features of chronic hepatitis C virus infection after blood transfusion in Japanese children

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

High viral load and mild liver injury in children with hemophilia compared with other children with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Hepatitis C in children

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Hepatitis C virus resistance to antiviral therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Does interferon and ribavirin combination therapy increase the rate of treatment response in children with hepatitis C?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

The effect of early treatment in children with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1124

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP1124

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference